Eli Lilly (LLY) is down -6.5%, or -$51.58 to $745.90.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Drugmakers to push Trump to pause price negotiations, Bloomberg reports
- Eli Lilly sees growth in 2025 from new medicines
- Eli Lilly cuts FY24 revenue view to ~$45B from $45.4B-$46B, consensus $45.55B
- Eli Lilly sees FY25 revenue $58B-$61B, consensus $58.48B
- Eli Lilly sees Q4 worldwide revenue ~$13.5B, consensus $13.95B